Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01645397 · ClinicalTrials.gov registry record

Exhaled Nitric Oxide and Airway Caliber in Children With Asthma

A clinical trial, sponsored by Atlantic Health System.

Completed
Registry status
20
Enrollment target

NCT01645397 is a clinical trial that has completed, run by Atlantic Health System. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01645397 has completed, sponsored by Atlantic Health System.

COMPLETED
Registry status
20 participants
Enrollment target

Study Summary

The purpose of this study is to assess if in steroid naïve asthmatic children with elevated baseline exhaled nitric oxide, treatment with inhaled steroid and normalization of exhaled nitric oxide level results in restoration of the bronchodilator response to deep inhalation.

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2011-06
Est. Completion 2013-08

Sponsor

Atlantic Health System

43 total trials

What the Registry Record Tells You About NCT01645397

The ClinicalTrials.gov registry entry for NCT01645397 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Atlantic Health System, which has 43 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01645397 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01645397 about?

NCT01645397 is a clinical study titled "Exhaled Nitric Oxide and Airway Caliber in Children With Asthma". The purpose of this study is to assess if in steroid naïve asthmatic children with elevated baseline exhaled nitric oxide, treatment with inhaled steroid and normalization of exhaled nitric oxide level results in restoration of the bronchodilator response to deep inhalation.

What is the current status of trial NCT01645397?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2011-06. Estimated completion is 2013-08.

Who is sponsoring clinical trial NCT01645397?

This trial is sponsored by Atlantic Health System, which has 43 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.